Literature DB >> 25660094

Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance solubility, stability, and bioavailability.

N P Aditya1, Hanjoo Yang2, Saehoon Kim3, Sanghoon Ko4.   

Abstract

Curcumin has low aqueous stability and solubility in its native form. It also has a low bioavailability which presents a major barrier to its use in fortifying food products. The aim of this work was to reduce the size of curcumin crystals to the nanoscale and subsequently stabilize them in an amorphous form. To this end, amorphous curcumin nanosuspensions were fabricated using the antisolvent precipitation method with β-lactoglobulin (β-lg) as a stabilizer. The resulting amorphous curcumin nanosuspensions were in the size range of 150-175 nm with unimodal size distribution. The curcumin particles were amorphous and were molecularly dispersed within the β-lg as confirmed by differential scanning calorimetry (DSC) and X-ray diffraction (XRD) studies. The solubility of the amorphous curcumin nanosuspension was enhanced ∼35-fold due to the reduced size and lower crystallinity. Among the formulations, the amorphous curcumin nanosuspensions stabilized with β-lg and prepared at pH 3.4 (β-lg-cur 3.4), showed maximum aqueous stability which was >90% after 30 days. An in vitro study using Caco-2 cell lines showed a significant increase in curcumin bioavailability after stabilization with β-lg.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphous; Antisolvent precipitation; Curcumin; Nanosuspension; β-Lactoglobulin

Mesh:

Substances:

Year:  2015        PMID: 25660094     DOI: 10.1016/j.colsurfb.2015.01.027

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  8 in total

1.  Development of nanocubosomes co-loaded with dual anticancer agents curcumin and temozolomide for effective Colon cancer therapy.

Authors:  Yosif Almoshari; Haroon Iqbal; Anam Razzaq; Khalil Ali Ahmad; Muhammad Khalid Khan; Saad Saeed Alqahtani; Muhammad Hadi Sultan; Barkat Ali Khan
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  Study of Competitive Displacement of Curcumin on α-zearalenol Binding to Human Serum Albumin Complex Using Fluorescence Spectroscopy.

Authors:  Yifang Li; Hongxia Tan; Hongyuan Zhou; Ting Guo; Ying Zhou; Yuhao Zhang; Xiaozhu Liu; Liang Ma
Journal:  Toxins (Basel)       Date:  2022-08-31       Impact factor: 5.075

3.  Characterization, Quantification, and Determination of the Toxicity of Iron Oxide Nanoparticles to the Bone Marrow Cells.

Authors:  Sae-Yeol-Rim Paik; Jong-Seok Kim; Sung Jae Shin; Sanghoon Ko
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

4.  Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.

Authors:  Haowen Li; Yijing Li; Hui Ao; Dongdong Bi; Meihua Han; Yifei Guo; Xiangtao Wang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

5.  Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy.

Authors:  Haowen Li; Biao Liu; Hui Ao; Jingxin Fu; Yian Wang; Yue Feng; Yifei Guo; Xiangtao Wang
Journal:  J Nanobiotechnology       Date:  2020-01-06       Impact factor: 10.435

6.  A novel and green nanoparticle formation approach to forming low-crystallinity curcumin nanoparticles to improve curcumin's bioaccessibility.

Authors:  Ali Ubeyitogullari; Ozan N Ciftci
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

7.  Effects of Baicalein and Chrysin on the Structure and Functional Properties of β-Lactoglobulin.

Authors:  Ang Li; Lei Chen; Weijie Zhou; Junhui Pan; Deming Gong; Guowen Zhang
Journal:  Foods       Date:  2022-01-09

Review 8.  Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer.

Authors:  Quhui Wu; Huiping Ou; Yan Shang; Xi Zhang; Junyong Wu; Fuyuan Fan
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.